Enterotoxin Septic Shock Protection and Deficient T Helper 2 Cytokine Production in Growth Hormone Transgenic Mice

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3298-3304

  Gonzalo, Jose A ^a   Mazuchelli, Ramon ^a   Mellado, Mario ^a   Frade, Jose M R ^a   Carrera, Ana C ^a   Von Kobbe, Cayetano ^a   Merida, Isabel ^a   Martinez A, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; GROWTH HORMONE; IMMUNOGLOBULIN G; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; SOMATOMEDIN C;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; COMPARATIVE STUDY; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; CATTLE; CYTOKINES; ENTEROTOXINS; FEMALE; GROWTH HORMONE; IMMUNOGLOBULIN G; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, TRANSGENIC; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; TH2 CELLS;

EID: 0030587814     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Li, C. H. 1976. Hormonal Proteins and Peptides. Vol. 2. C. H. Li, ed. Academic Press, New York, p. 1.
2. Nagy, E., and I. Berczi. 1978. Immunodeficiency in hypophysectomized rats. J. Acta Endocrinol. 89:530.
3. Buchanan, C. R., and M. A. Preece. 1992. Hormonal control of bone growth. In Bone Growth, Vol 6. B. K. Hall, ed. CRC Press, Boca Raton, FL, p. 53.
4. Wüster, C. 1993. Growth hormone and bone metabolism. Acta Endocrinol. 128: 14.
5. Hooghe, R., M. Delhase, P. Vergani, A. Malur, and E. L. Hooghe-Peters. 1993. Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol. Today 14:212.
6. Murphy, W. I., S. K. Durum, and D. L. Longo. 1993. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178:231.
7. Dardenne, M., and W. Savino. 1994. Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 15:518.
8. Derijk, R., and F. Berkenbosch. 1991. The immune-hypothalamo-pituitary adrenal axis and autoimmunity. Int. J. Neurosci. 59:91.
9. Rivier, C., R. Chizzonite, and W. Vale. 1989. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin 1. Endocrinology 125:2800.
10. Chensue, S. W., P. D. Terebuh, D. G. Remick, W. E. Scales, and S. L. Kunkel. 1991. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia, kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138:395.
11. Jacobson, L., and R. Sapolsky. 1991. The role for the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12: 118.
12. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, and G. C. Kuo. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacterimia. Nature 330:66.
13. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. J. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91.
14. Beutler, B., J. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229:869.
15. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu, T. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
16. Tzung, S.-P., T. C. Mahl, P. Lance, V. Andersen, and S. A. Cohen. 1992. Interferon-alpha prevents endotoxin-induced mortality in mice. Eur. J. Immunol. 22: 3097.
17. Gadina, M., R. Bertini, M. Mengozzi, M. Zandalasini, A. Mantovani, and P. Ghezzi. 1991. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J. Exp. Med. 173:1305.
18. Gonzalo, J. A., E. Baixeras, A. Gonzàlez-Garcia, G. Chandy, N. van Rooijen, C. Martínez-A., and G. Kroemer. 1994. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor: activation-induced cell death versus passive macrophage-dependent deletion. J. Immunol. 152:1597.
19. Gonzalo, J. A., I. Moreno, J. E. Alés-Martínez, C. Martínez-A., and G. Kroemer. 1992. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin 2 pathway. Eur. J. Immunol. 22: 1007.
20. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur. J. Immunol. 21:1963.
21. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:2101.
22. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091.
23. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
24. + T cells. Annu. Rev. Immunol. 12:635.
25. McGrane, M. J. de Vente, J. Yun, J. Bloom, E. Park, B. Wynshaw, T. Wagner, F. M. Rottman, and R. W. Hanson. 1988. Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 263:11443.
26. Andreu-Sánchez, J. L., I. Moreno de Alborán, M. A. R. Marcos, A. Sánchez-Movilla, C. Martínez-A., and G. Kroemer. 1991. IL-2 abrogates the non-responsive state of T cells expressing a forbidden TCR repertoire and induces autoimmune disease in neonatally thymectomized mice. J. Exp. Med. 173:1325.
27. Kopf, M., G. Le Gros, M. Bachmann, L. C. Marinus, B. Horst, and K. Georges. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
28. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1991. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171: 455.
29. Alegre, M.-L., P. Vandenabeele, M. Depierreux, S. Florquin, M. Deschodt-Lanckman, V. Flamand, N. Moserin, O. Leo, J. Urbain, W. Fiers, and M. J. Goldman. 1991. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. Immunology 146:1184.
30. Glauser, M. P., G. Zanetti, J. P. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 2:732.
31. Cohen, J., and M. P. Glauser. 1991. Septic shock: treatment. Lancet 2:736.
32. Waage, A., and T. Espevik. 1988. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J. Exp. Med. 167:1987.
33. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence of IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor. J. Immunol 149:1666.
34. Aroeira-Stark, L., O. Williams, and C. Martínez-A. 1994. Lack of clonal deletion and induction of anergy by SEB in nude mice reconstitute with T cells. Eur. J. Immunol 24:579.
35. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R-C. Thompson. 1991. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550.
36. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
37. Gonzalo, J. A., A. G. García, C. Martínez-A., and G. Kroemer. 1993. Glucocorticoids control the activation and clonal deletion of peripheral T cells in vivo. J. Exp. Med. 177:1239.
38. Gonzalo, J. A., A. G. García, T. Kalland, G. Gedlund, and C. Martínez-A. 1994. Linomide inhibits programmed cell death of peripheral T cells in vivo. Eur. J. Immunol. 24:48.
39. Vassalli, P. 1992. The lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10:411.
40. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Galley, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon-γ receptor-deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437.
41. Rodriγguez-Tarduchy, G., M. L. Collins, J. García, and A. López Rivas. 1992. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 149:535.
42. Murphy, W. J., G. Tsafarty, and D. L. Longo. 1992. Growth hormone exerts hematopoietic growth-promoting effects in vivo. Blood 80:1443.
43. Murphy, W. I., S. K. Durum, and D. L. Longo. 1992. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. USA 89:4481.
44. Migita, K., and A. Ochi. 1993. The fate of anergic T cells in vivo. J. Immunol. 150:763.
45. Le-Gros, B., S. J. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
46. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
47. Locksley, R. M. 1994. Th2 cells: help for helminths. Cell 179:1405.
48. Mosmann, T. R., and K. W. Moare. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12:49.
49. Rook, G. A. W., R. Hernàndez-Pando, and S. L. Lightman. 1994. Immunol. Today 15:301.